Ligand validation:9MIQ

VOV: harderoheme (III)

VOV is a Ligand Of Interest in 9MIQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9MIQ_VOV_B_301	86%	41%	0.095	0.964	0.89	1.41	1	11	1	1	100%	1
9MIQ_VOV_J_301	83%	44%	0.104	0.963	0.94	1.23	2	7	3	1	100%	1
9MIQ_VOV_H_301	82%	45%	0.103	0.958	0.93	1.17	2	7	2	1	100%	1
9MIQ_VOV_D_301	82%	40%	0.104	0.958	0.91	1.4	2	11	0	1	100%	1
9MIQ_VOV_E_301	78%	42%	0.109	0.952	0.94	1.31	2	7	1	1	100%	1
9MIQ_VOV_G_301	76%	39%	0.109	0.944	1	1.39	3	9	1	1	100%	1
9MIQ_VOV_C_301	69%	37%	0.125	0.939	1.05	1.43	4	11	3	1	100%	1
9MIQ_VOV_F_301	69%	40%	0.123	0.936	0.95	1.39	2	8	2	1	100%	1
9MIQ_VOV_I_301	59%	41%	0.136	0.917	0.91	1.39	2	8	1	1	100%	1
9MIQ_VOV_A_301	53%	37%	0.15	0.91	1.01	1.44	4	10	2	1	100%	1
9MHQ_VOV_C_501	100%	50%	0.047	0.991	0.79	1.14	1	6	2	1	100%	0.91
9MHR_VOV_D_301	93%	48%	0.08	0.976	0.82	1.16	2	5	1	1	100%	1
6FXQ_VOV_D_302	54%	29%	0.153	0.916	1.43	1.39	5	9	0	1	100%	0.29
6XUB_VOV_E_401	35%	29%	0.191	0.88	1.45	1.37	6	11	2	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.